X-Chem

Glamorous AI is a developer of an advanced artificial intelligence-based drug discovery platform that focuses on low-data drug discovery. The platform utilizes AI to identify and optimize novel chemical scaffolds and screen extensive chemical libraries. By leveraging a large repository of pre-trained and customizable AI models, Glamorous AI addresses the challenges posed by sparse, noisy, and limited data. This innovative approach enables researchers to explore complex compounds and facilitates the discovery of first-in-class therapeutics, ultimately aiming to drive advancements in medicine and contribute to curing diseases.

ComInnex is a global provider of synthetic chemistry services and novel chemical technologies, supporting early-stage drug discovery for pharmaceutical companies, biotech startups, academic institutions, and government agencies worldwide. The company offers small molecule design, chemical library development and synthesis, project management, and customer service, prioritizing open communication, quick reaction times, and confidentiality to meet clients' needs efficiently.

IntelliSyn providers of medicinal chemistry support in North America. Our team of experienced scientists (>80% PhD), at our state-of-the-art facilities in Montreal, specializes in identifying novel leads and optimizing them as successful clinical candidates for our collaborators across Major Pharma and Biotech. IntelliSyn provide discovery support (computational chemistry, design, synthesis, and DMPK) where innovation, intellectual property security, and proven delivery-expertise are needed on an expert basis. Our discipline expertise ranges across CNS, oncology, metabolic diseases as well as other specialized areas including structure-based design, GPCR modulators, and ion channel modulators.